COMMUNIQUÉS West-GlobeNewswire

MULTIMEDIA UPDATE: AVAVA™ Receives FDA Clearance for Revolutionary Acne Scar Treatment using Focal Point Technology™

22/04/2025 - 19:50

BOSTON, April 22, 2025 (GLOBE NEWSWIRE) -- AVAVA™, a medical aesthetics innovation company redefining energy-based skin therapy, announced today that its advanced acne scar treatment using Focal Point Technology™ has [...]

Cronos Unveils New Spinach® 1.2g Vapes and SOURZ by Spinach® Gummies Enhanced with Rare Cannabinoids

22/04/2025 - 14:00

TORONTO, April 22, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc.’s (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) best-selling cannabis brand, Spinach®, is thrilled to introduce three all-new 1.2g vape products, [...]

Daxor Corporation to Exhibit at the 45th International Society for Heart and Lung Transplant (ISHLT) Annual Meeting and Scientific Sessions

22/04/2025 - 14:00

Daxor Brings Advanced Blood Volume Analysis Solutions to Elite Heart and Lung Transplantation Forum Oak Ridge, TN, April 22, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume [...]

Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025

22/04/2025 - 14:03

The Company will Host a Conference Call and Webcast on May 8, 2025, at 8:30 AM ET CORAL GABLES, Fla., April 22, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a [...]

SCIENTURE announces manufacturing and supply chain readiness for ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL for a target product launch in July 2025.

22/04/2025 - 14:05

TAMPA, FL, April 22, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, [...]

Theranica Announces Coverage Policy from the Second Largest U.S. Health Insurer for Its Nerivio® REN Wearable Migraine Treatment, Reaching Access for 80 Million Americans

22/04/2025 - 14:10

The policy expands access to this effective, non-drug treatment for members as young as 8 years old who are diagnosed with migraine BRIDGEWATER, N.J. and NETANYA, Israel, April 22, 2025 (GLOBE NEWSWIRE) -- Theranica , a [...]

BlueGenes Partners with Level Care to Revolutionize Medication Management for Union Members

22/04/2025 - 14:15

SCOTTSDALE, Ariz., April 22, 2025 (GLOBE NEWSWIRE) -- BlueGenes , a pioneering technology company specializing in permission medicine, today announced a strategic partnership with Level Care, the healthcare division of [...]

The Best Natural Testosterone Booster Supplements For Men:~ Honest Customer Reviews 2025

22/04/2025 - 14:17

NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- Low testosterone levels can cause many problems in men, such as less muscle, less energy, less libido and low mood. You may want to find a solution, but you don’t know which [...]

Transactions under Novonesis’ share buyback program

22/04/2025 - 14:25

Please read the announcement in PDF Attachment 2025_19_Share_buyback_program

Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call

22/04/2025 - 14:30

MALVERN, Pa., April 22, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who [...]

Intelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening System

22/04/2025 - 14:30

Company expands Intelligent Fingerprinting Drug Screening System multilingual capabilities to meet growing demand across Latin American Spanish-speaking markets Latin American drug screening market projected to reach [...]

Enzo Biochem, Inc. Announces Review of Strategic Alternatives after Receiving Multiple Inquiries Regarding a Potential Transaction

22/04/2025 - 14:30

Forms Special Committee of the Board to Lead Evaluation of Viable Options for Maximizing Shareholder Value Engages Independent Financial and Legal Advisors to Support Thorough Process Remains Committed to Maintaining [...]

Rakovina Therapeutics Congratulates Scientific Advisor Dr. Artem Cherkasov on Global Recognition for Breakthrough AI Innovation in Drug Discovery

22/04/2025 - 14:30

VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)- [...]

Day One to Report First Quarter 2025 Financial Results Tuesday, May 6, 2025

22/04/2025 - 14:30

BRISBANE, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for [...]

Ernexa Therapeutics Announces New Data to be Presented at AACR Annual Meeting 2025

22/04/2025 - 14:30

Conference attendees will get first look at new data that supports the potential of ERNA-101 to boost anti-tumor immunity in ovarian cancer CAMBRIDGE, Mass., April 22, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics ( [...]

AP Biosciences Doses First Patient in Phase 1/2 Clinical Trials of AP402 for HER2+ Cancer Patients

22/04/2025 - 14:30

TAIPEI, Taiwan, April 22, 2025 (GLOBE NEWSWIRE) -- AP Biosciences, a clinical-stage biopharmaceutical company dedicated to transforming cancer therapy through development of innovative bispecific antibodies, today [...]

Tarsus to Present Several Scientific Abstracts Highlighting the Global Prevalence of Demodex Blepharitis and the Clinical Impact of XDEMVY at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 Annual Meeting

22/04/2025 - 14:31

IRVINE, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) will present four distinct data sets highlighting the global prevalence and real-world patient burden of Demodex blepharitis [...]

Babesiosis Disease Burden in United States is Substantially Higher Than Official Estimates, According to Preliminary Results of 60 Degrees Pharma Survey

22/04/2025 - 14:44

In a survey representative of the general U.S. adult population, 1.26 percent of respondents – equivalent to about 3 million people – reported having received a medical diagnosis of babesiosis during their life-time; [...]

Nerve Freedom Reviews [Investigated Complaints] Nerve Alive Best Neuropathy Supplement for Nerve Pain Relief Naturally

22/04/2025 - 14:49

Nerve Freedom is a top-rated supplement for neuropathy & nerve pain relief. Targets inflammation, supports nerve regeneration. Try it risk-free! LAKELAND, Fla., April 22, 2025 (GLOBE NEWSWIRE) -- Introduction to [...]